Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:

Green Cross to Form Cell Therapy Company in China

publication date: Mar 13, 2015
Green Cross, a South Korean biopharma, signed a MOU earlier this month with China's Guizhou provincial government to build a cell therapy manufacturing and distributing center in Guizhou, a southwestern province of China. The company offers a portfolio of approved and investigational cell therapy projects including T cell, NK cell, dendritic cell and stem cells. As a reason for the investment, Green Cross cited the increasing global interest in cell therapy treatments for serious diseases. More details....

Share this with colleagues:  

This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China